4/A//SEC Filing
KENYON LAWRENCE A 4/A
Accession 0001209191-19-053184
CIK 0001649989other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 5:08 PM ET
Size
6.4 KB
Accession
0001209191-19-053184
Insider Transaction Report
Form 4/AAmended
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Sale
Common Stock
2019-09-18$1.70/sh−1,350$2,295→ 8,926 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 - $1.705, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001230484
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 5:08 PM ET
- Size
- 6.4 KB